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Background: Left ventricular (LV) lead placement to the latest area of contraction is associated with enhanced response to cardiac 
resynchronization therapy (CRT). We conducted a randomised controlled trial to compare the effect on acute change in cardiac output (CO) between 
patients undergoing either echocardiographically guided LV lead placement or standard usual CRT implantation.
Methods: A total of 180 patients with left bundle branch block (age 71 ± 8 yrs, NYHA III 92%, EF 23 ± 7%, QRS 156 ± 9 ms) were recruited and 
underwent speckle tracking 2D radial strain at baseline to determine the latest site of activation. Patients were subsequently randomized into one 
of 2 groups. In group 1 (targeted group - TAR) the CRT implanters were aware of the echocardiographic findings and attempted to position the LV 
lead to the latest site of activation. In group 2 (control - CON) patients underwent standard CRT implantation without echocardiographic guidance. 
In all patients the LV lead position was defined by biplane fluoroscopy. Patients were classified according to the relation of the LV lead to the latest 
site as: Concordant (C - lead position at latest site), Adjacent (A - within 1 segment) or Remote (R - 2 or more segments away from latest site). All 
patients underwent AV and VV delay optimization. Within 24 hours of implantation all patients underwent non invasive CO determination using a 
commercially available system (NICOM) during optimised CRT and with CRT switched off (baseline). The peak improvement in CO was compared 
between the two groups.
Results: There were no differences in baseline characteristics between the two groups. There were more C and less R leads in the targeted group 
(TAR vs. CON: C 68.9% vs 46.7% p<0.01, A: 24.4% vs. 30.0% p=0.46, R: 6.7% vs. 23.3% p<0.01). There were no differences in CO at baseline 
between the two groups (TAR vs. CON: 4.77 ± 1.1 vs. 4.67 ± 1.1 L/min, p=0.76). CO was significantly higher during CRT in patients with a targeted LV 
lead compared to the control group (6.06 ± 1.3 vs 5.57 ± 1.2 L/min, p=0.021).
Conclusions: Targeting LV lead placement to the latest areas of activation using speckle tracking 2D radial strain is associated with a better CO 
response to CRT compared to standard treatment. 
